Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma
Clinical trial NCT03782532 · COMPLETED
Trial details
- NCT number
- NCT03782532
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-25
- Primary completion
- 2022-05-21
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.